The pharmaceutical company Gilead has announced that the price of their antiviral, used with modest results to treat COVID-19, will be 2083 Euros per patient when the minimum cost of production is 0.83 Euros per dose. The price of medicines should be related to the cost of development and production, plus a fair and reasonable profit, particularly in light of the public effort that has been invested in the R&D chain.
Control measures to overcome the COVID-19 pandemic affect different population sectors in radically different ways. In the current, almost dystopian situation, social determinants of health are more clearly shown.
A group of mostly Spanish male and female physicists and physicists have expressed their rejection of Alessandro Strumia's repeated statements on women's access to his discipline, which have been harshly criticised for their lack of rigour. This letter is an initiative of the Association of Women Researchers and Technologists (AMIT).
Although we are aware that the planet has limits, we find it difficult to live in a sustainable way. Our cognitive biases are partly to blame. So far, communication professionals have only reinforced them by creating a story about climate change that leaves us cold.